Moyamoya syndrome in a patient with pathogenic heterozygous variant in the SETD5 gene: A case report
Brain Circulation · 2026-04 · 12 (2) · 183-186
DOI: 10.4103/bc.bc_78_24 ↗Kurz gefasst
Fallbericht in der Zeitschrift Brain Circulation, online erschienen am 03.04.2025. Verfasst von Larissa Dams und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Alfried Krupp Hospital, Essen, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A 25-year-old patient with dysmorphic facies presented with tingling in both hands and a speech disorder that occurred for a few hours approximately once a month since the age of 12 years. A magnetic resonance angiography of the brain showed signs of a bilateral moyamoya phenomenon with distal carotid artery occlusions with significant collateral vessel formation and bilateral posterior cerebral artery occlusions. In addition, there was an extracranial, nonatherosclerotic carotid artery stenosis. Genetic testing identified a heterozygous de novo , loss-of-function variant in SETD5 , which was classified pathogenic according to the American College of Medical Genetics and Genomics criteria. This case report describes a newfound SETD5 pathogenic variant in a patient with moyamoya syndrome, but surprisingly without intellectual disability. Furthermore, our patient suffered from nonarteriosclerotic extracranial carotid artery stenosis, which is distinctly unusual in patients with moyamoya angiopathy. This raises the possibility that the occlusive vascular disease in patients with SETD5 variants may extend beyond the cerebrovascular circulation. In summary, this case presents a moyamoya patient with an unusual vascular feature which can be explained with the newfound SETD5 mutation variant.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Alfried Krupp Hospital, Essen, Germany.
- Department of Internal Medicine, Division of Medical Genetics, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
- Centogene GmbH, Rostock, Germany.
- Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Zitieren
APA
Dams, L., Milewicz, D. M., Bauer, P., & Kraemer, M. (2026). Moyamoya syndrome in a patient with pathogenic heterozygous variant in the SETD5 gene: A case report. Brain Circulation, 12(2), 183-186. https://doi.org/10.4103/bc.bc_78_24
Vancouver
Dams L, Milewicz DM, Bauer P, Kraemer M. Moyamoya syndrome in a patient with pathogenic heterozygous variant in the SETD5 gene: A case report. Brain Circulation. 2026;12(2):183-186. doi:10.4103/bc.bc_78_24
BibTeX
@article{Dams2026,
author = {Dams, Larissa and Milewicz, Dianna M and Bauer, Peter and Kraemer, Markus},
title = {Moyamoya syndrome in a patient with pathogenic heterozygous variant in the SETD5 gene: A case report},
journal = {Brain Circulation},
year = {2026},
volume = {12},
number = {2},
pages = {183--186},
doi = {10.4103/bc.bc_78_24}
}
EUVIMED